Generate a tailored SOP for Dr. Holger Auner. Improve your application with a focused, well-structured draft.
Holger Auner received his MD from Karl-Franzens University Graz, Austria, and trained in Internal Medicine and Hematology-Oncology. He studied genetic instability in myeloid leukemias in the laboratory of Professor Heinz Sill and joined Professor Niall Dillon's group at the MRC Clinical Sciences Centre as a Kay Kendall Leukaemia Fund Junior Research Fellow. He obtained his PhD for work on plasma cell biology at Imperial College London and subsequently served as the Stem Cell Transplant Coordinator at the Centre for Haematology at Hammersmith Hospital. Auner has been awarded the Cancer Research UK Clinician Scientist Fellowship in 2012 and the Advanced Clinician Scientist Fellowship in 2019, eventually becoming Head of Translational Research at Imperial's newly established Hugh Josseline Langmuir Centre for Myeloma Research. In 2022, he was appointed Professor of Clinical Molecular Hemato-oncology at Imperial College. His primary research interest is to understand the molecular mechanisms that coordinate protein degradation pathways and cellular metabolism in multiple myeloma cancers, with the ultimate goal of finding novel therapeutic approaches. His lab, focusing on cancer cell protein metabolism, investigates the dependency of proteomic metabolic homeostasis on tissue physical properties and vice versa, using time-resolved omics approaches and fostering a range of cross-disciplinary collaborations.
Imperial College London • London, United Kingdom
Part of research program continued from Imperial College while relocating to University Hospital Lausanne.
Imperial College London • London, United Kingdom
Teaching and research in clinical hematology.
Imperial College London • London, United Kingdom
Leading research and clinical activities in molecular hematology.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.